Table 5.
Individual variables for SES and access to care in association with treatment duration by treatment modality in Carolina Breast Cancer Study 3 (2008-2013)
| Treatment durationa |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgery & radiation |
Surgery & chemotherapy |
Surgery, radiation & chemo. |
||||||||||
| Q1-3 (73.5%) | Q4 (26.5%) | Q1-3 (73.5%) | Q4 (26.5%) | Q1-3 (73.5%) | Q4 (26.5%) | |||||||
| No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | |
| Uninsured | ||||||||||||
| No | 467 | (74.3) | 161 | (25.6) | 276 | (74.2) | 96 | (25.8) | 1000 | (75.6) | 323 | (24.4) |
| Yes | 19 | (61.3) | 12 | (38.7) | 20 | (83.3) | 4 | (16.7) | 61 | (65.6) | 32 | (34.4) |
| RFD (95% CI) | ref | 13.1% (−4.4, 30.6) | ref | −9.1% (−24.7, 6.4) | ref | 10.0% (0.1, 19.9) | ||||||
| Financial issues | ||||||||||||
| No | 425 | (75.4) | 139 | (24.7) | 229 | (75.1) | 76 | (24.9) | 812 | (77.3) | 239 | (22.7) |
| Yes | 40 | (60.6) | 26 | (39.4) | 49 | (74.2) | 17 | (25.1) | 176 | (68.0) | 83 | (32.0) |
| RFD (95% CI) | ref | 14.8% (2.4, 27.1) | ref | 0.8% (−10.8, 12.5) | ref | 9.3% (3.1, 15.5) | ||||||
| Transportation issues | ||||||||||||
| No | 448 | (74.8) | 151 | (25.2) | 250 | (76.0) | 79 | (24.0) | 1124 | (77.0) | 381 | (23.0) |
| Yes | 15 | (50.0) | 15 | (50.0) | 26 | (65.0) | 14 | (35.0) | 109 | (61.2) | 60 | (38.8) |
| RFD (95% CI) | ref | 24.8% (6.6, 43.0) | ref | 11.0% (−4.5, 26.5) | ref | 15.7% (7.0, 24.5) | ||||||
| Job loss due to diagnosis | ||||||||||||
| No | 472 | (74.2) | 164 | (25.8) | 284 | (75.1) | 94 | (24.9) | 1012 | (75.2) | 333 | (24.8) |
| Yes | 10 | (76.9) | 3 | (23.1) | 11 | (68.8) | 5 | (31.2) | 42 | (67.7) | 20 | (32.3) |
| RFD (95% CI) | ref | −2.7% (−25.9, 20.4) | ref | 6.4% (−16.7, 29.5) | ref | 7.5% (−4.4, 19.4) | ||||||
a
n = 368, 659, 397, and 1417 for surgery only, surgery + radiation, surgery + chemotherapy, and surgery + radiation + chemotherapy, respectively
Abbreviations: CI, confidence interval; RFD, relative frequency difference